Search

Jazz Pharmaceuticals PLC

Geschlossen

BrancheGesundheitswesen

255.93 -0.22

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

254.7

Max

258

Schlüsselkennzahlen

By Trading Economics

Einkommen

-100M

193M

Verkäufe

139M

1.2B

KGV

Branchendurchschnitt

2,528.6

68.51

EPS

4.89

Gewinnspanne

15.956

Angestellte

2,890

EBITDA

-296M

248M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+10.59% upside

Dividenden

By Acuity

Nächstes Ergebnis

4. Nov. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

2.8B

16B

Vorheriger Eröffnungskurs

256.15

Vorheriger Schlusskurs

255.93

Nachrichtenstimmung

By Acuity

29%

71%

73 / 340 Ranking in Healthcare

Jazz Pharmaceuticals PLC Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

7. Aug. 2026, 19:36 UTC

Jazz Pharmaceuticals shares are higher today, reflecting broader market gains amid expectations the Federal Reserve may pause interest rate hikes.

6. Aug. 2026, 19:21 UTC

Jazz Pharmaceuticals PLC shares are lower today, despite earlier gains. Mixed economic signals contribute to cautious sentiment ahead of the non-farm payrolls report.

5. Aug. 2026, 19:36 UTC

News

Shares of Jazz Pharmaceuticals PLC are lower today, despite earlier gains. The company raised its full-year revenue guidance, driven by strong performance from Xywav.

4. Aug. 2026, 20:04 UTC

Social Media
News

Jazz Pharmaceuticals PLC shares rise as analysts upgrade price targets, following strong Q2 results that beat revenue estimates and boosted 2026 sales guidance.

3. Aug. 2026, 23:02 UTC

News

Jazz Pharmaceuticals reported Q2 revenues of $1.208 billion, exceeding expectations. Shares advanced in after-market trading following the raised full-year guidance.

31. Juli 2026, 23:21 UTC

Jazz Pharmaceuticals PLC shares are lower in after-market trading, pulled back from earlier session highs amid broader market declines, particularly in major tech stocks.

30. Juli 2026, 19:59 UTC

Jazz Pharmaceuticals shares are higher, reflecting broader market recovery amid significant gains in the technology sector. The stock is near the upper end of its one-month range.

29. Juli 2026, 18:26 UTC

Jazz Pharmaceuticals PLC is trading higher during Wednesday's session, with fluctuations within a routine range and positioned above its 20-day moving average.

28. Juli 2026, 23:46 UTC

Jazz Pharmaceuticals PLC shares are higher in after-market trading, recovering from an early low and remaining above the 20-day moving average.

27. Juli 2026, 19:37 UTC

Social Media

Jazz Pharmaceuticals PLC is trading higher, recently reaching a new 52-week high amid increased investor interest and significant average volume exceeding $50 million.

24. Juli 2026, 20:07 UTC

Jazz Pharmaceuticals PLC shares are lower today amid broader market dynamics influenced by recent oil price volatility, despite remaining above its 20-day moving average.

21. Juli 2026, 19:02 UTC

Jazz Pharmaceuticals PLC is trading higher today, despite no specific news. Positive sentiment in the semiconductor sector may be contributing to overall investor optimism.

20. Juli 2026, 23:36 UTC

News

Jazz Pharmaceuticals PLC will report second-quarter results on August 3, contributing to positive investor sentiment as shares trade higher after market hours.

Peer-Vergleich

Kursveränderung

Jazz Pharmaceuticals PLC Prognose

Kursziel

By TipRanks

10.59% Vorteil

12-Monats-Prognose

Durchschnitt 283.82 USD  10.59%

Hoch 315 USD

Tief 229 USD

Basierend auf 17 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Jazz Pharmaceuticals PLC – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

17 ratings

16

Buy

1

Halten

0

Sell

Stimmung

By Acuity

73 / 340 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

help-icon Live chat